MedPath

Climara Pro

These highlights do not include all the information needed to use CLIMARA PRO safely and effectively. See full prescribing information for CLIMARA PRO. Initial U.S. Approval: 1975

Approved
Approval ID

184d3092-7fc6-4375-816b-1ab06bb99cfd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 6, 2023

Manufacturers
FDA

Bayer HealthCare Pharmaceuticals Inc.

DUNS: 005436809

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Estradiol and Levonorgestrel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50419-491
Application NumberNDA021258
Product Classification
M
Marketing Category
C73594
G
Generic Name
Estradiol and Levonorgestrel
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateNovember 1, 2017
FDA Product Classification

INGREDIENTS (2)

LEVONORGESTRELActive
Quantity: 0.015 mg in 1 d
Code: 5W7SIA7YZW
Classification: ACTIB
ESTRADIOLActive
Quantity: 0.045 mg in 1 d
Code: 4TI98Z838E
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.